top of page

Conference Speaker Biography
- Dr Robert Weinkove

Programmes

Rob Weinkove.jpg

Dr Robert Weinkove is the Clinical Director at the Malaghan Institute of Medical Research (MIMR), and a Consultant Haematologist at Te Whatu Ora Health New Zealand. After studying medicine at the University of Cambridge and Kings College London, he trained in clinical haematology in London and in Hannover and undertook a PhD in immunology at the University of Otago.

 

Dr Weinkove leads a clinical and translational chimeric antigen receptor (CAR) T-cell programme at the Malaghan Institute and is the Principal Investigator of ENABLE (NCT04049513), a phase 1 trial of a new third-generation CAR T-cell therapy for B-cell lymphomas. Dr Weinkove is an active member of the Australasian Leukaemia & Lymphoma Group and contributes to clinical trials and guidelines in the fields of B-cell leukaemias/lymphomas, and infection prophylaxis for immunosuppressed patients.

bottom of page